Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting Non-phase study NCT06447974

The Barts Charity Children’s Environmental Health Clinic

The Barts Charity Children’s Environmental Health Clinic — Recruiting • Non-phase study • Respiratory / COPD / Asthma • NCT06447974.

📅 13 Aug 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT06447974
Sponsor
Queen Mary University of London
Start
2025-07-24
ClinicaliQ Trial Snapshot
  • The Barts Charity Children’s Environmental Health Clinic — Recruiting • Non-phase study • Respiratory / COPD / Asthma • NCT06447974.
  • What is being tested: Personal environmental exposure monitoring combined with home environmental assessments in children with chronic respiratory conditions to identify and characterise environmental triggers affecting their health.
  • Patient eligibility: Children with established chronic respiratory conditions managed through an NHS children's environmental health service, with assessments conducted both at home and via personal monitoring devices.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The study will be based from a newly formed NHS service, the children's environmental health service. Participants will be children with a known chronic respiratory condition. Participants will undergo personal environmental exposure monitoring as well as home environmental assessments, before personalised exposure reports will be provided including a summary of their exposure and advising mitigation strategies based on exposure patterns and behaviours. The monitoring will be repeated after introduction of mitigation strategies. This will allow a comparison of the effectiveness of each method of mitigation.

Eligibility Snapshot
  • : * Parent/Guardian able to provide written informed consent Referral made by paediatric asthma team Child aged 4-17 years at the time of consent to study A diagnosis of a chronic respiratory condition (diagnosis by a medical professional) Contactable for regular follow up by the research team Reasonable level of English language Ability to engage with technology and devices used in the study

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
Over one million children referred for mental healthcare – with anxiety the main reason
Respiratory / COPD / Asthma · BBC Health · 29 Jun 2026
Over one million children in England have been referred for mental healthcare, with anxiety as the leading presenting complaint, indicating a substantial…
View brief →
Clinical Brief
Why illegal children’s homes are being paid up to £2m per child by councils
Respiratory / COPD / Asthma · BBC Health · 20 May 2026
Councils are circumventing regulations by continuing to fund placements in unregistered children's homes despite legal prohibitions, creating significant safeguarding risks for vulnerable…
View brief →
Clinical Brief
Motherhood not all warm and fuzzy: Bollywood actor’s play spotlights messier side
Respiratory / COPD / Asthma · BBC Health · 09 Jul 2026
Maternal mental health and wellbeing deserve greater clinical recognition and discussion, as societal expectations often diminish the psychological burden of motherhood Healthcare…
View brief →
Guideline
Mepolizumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils
Respiratory / COPD / Asthma · 17 Jun 2026
Mepolizumab is recommended for patients with uncontrolled COPD and blood eosinophils ≥100 cells/μL; check eosinophil levels before initiating treatment as this is…
View guideline →
Clinical Brief
Amiodarone: reminder of risks of treatment and need for patient monitoring and supervision
Respiratory / COPD / Asthma · MHRA · 20 May 2026
Amiodarone carries serious risks of pulmonary, hepatic, and thyroid toxicity requiring regular patient monitoring and supervision throughout treatment Healthcare professionals must ensure…
View brief →
Clinical Brief
There’s a reason child vaccination rates are falling – and it’s not social media
Respiratory / COPD / Asthma · BBC Health · 03 Aug 2026
Vaccination rates declining across UK: Child immunisation coverage is falling below safe thresholds needed for herd immunity, creating vulnerability to vaccine-preventable disease…
View brief →